Correlates of continued tobacco use and intention to quit smoking among Russian cancer patients

International Journal of Behavioral Medicine

Volumn 18, Issue 4, 2011, Pages 325-332

  Schnoll, Robert A ^a   Subramanian, Somasundaram ^b   Martinez, Elisa ^a   Engstrom, Paul F ^c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b N N BLOKHIN RUSSIAN CANCER RESEARCH CENTER   (Russian Federation)

^c FOX CHASE CANCER CENTER   (United States)

Author keywords

Cancer patients; Russia; Smoking cessation; Tobacco

Indexed keywords

ADULT; AGED; ARTICLE; ATTITUDE TO HEALTH; COLORECTAL TUMOR; CROSS-SECTIONAL STUDY; FEMALE; HEAD AND NECK TUMOR; HUMAN; LUNG TUMOR; MALE; MIDDLE AGED; NEOPLASM; PSYCHOLOGICAL ASPECT; RUSSIAN FEDERATION; SMOKING; SMOKING CESSATION; STATISTICS; TOBACCO;

ADULT; AGED; COLORECTAL NEOPLASMS; CROSS-SECTIONAL STUDIES; FEMALE; HEAD AND NECK NEOPLASMS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASMS; RUSSIA; SMOKING; SMOKING CESSATION; TOBACCO;

EID: 84857040129     PISSN: 10705503     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12529-010-9131-8     Document Type: Article

References (43)

1. Cox LS, Africano NL, Tercyak KP, Taylor KL. Nicotine dependence treatment for patients with cancer. Cancer. 2003;98:632-44.
2. Schnoll RA, James C, Malstrom M, Rothman RL, Wang H, et al. Longitudinal predictors of continued tobacco use among patients diagnosed with cancer. Ann Beh Med. 2003;25:214-22.
3. Klosky JL, Tyc VL, Garces-Webb DM, Buscemi J, Klesges RC, Hudson MM. Emerging issues in smoking among adolescent and adult cancer survivors: A comprehensive review. Cancer. 2007;110:2408-19. (Pubitemid 350174925)
4. Zhou W, Heist RS, Liu G, Park S, Neuberg DS, Asomaning K, et al. Smoking cessation before diagnosis and survival in early stage non-small cell lung cancer patients. Lung Cancer. 2006;53:375-80. (Pubitemid 44189564)
5. Garces YI, Schroeder DR, Nirelli LM, Croghan GA, Croghan IT, Foote RL, et al. Second primary tumors following tobacco dependence treatments among head and neck cancer patients. Am J Clin Oncol. 2007;30:531-9. (Pubitemid 47537956)
6. Duarte RL, Luiz RR, Paschoal ME. The cigarette burden (measured by the number of pack-years smoked) negatively impacts the response rate to platinum-based chemotherapy in lung cancer patients. Lung Cancer. 2008;61:244-54.
7. Tsao AS, Liu D, Lee JJ, Sptiz M, Hong WK. Smoking affects treatment outcome in patients with advanced nonsmall cell lung cancer. Cancer. 2006;106:2428-36. (Pubitemid 43787667)
8. Daniel M, Keefe FJ, Lyna P, Peterson B, Garst J, Kelley M. Persistent smoking after a diagnosis of lung cancer is associated with higher reported pain levels. J Pain. 2009;10:323-8.
9. Zevallos JP, Mallen MJ, Lam CY, Karam-Hage M, Blalock J, Wetter DW, et al. Complications of radiotherapy in laryngopharyngeal cancer: effects of a prospective smoking cessation program. Cancer. 2009;115:4636-44.
10. Gritz ER, Sarna L, Dresler C, Healton CG. Building a united front: Aligning the agendas for tobacco control, lung cancer research, and policy. Cancer Epidemiol Biomark Prev. 2007;16:859-63. (Pubitemid 46910081)
11. Fiore MC, Jaen CR, Baker TB, Bailey WC, Benowitz NL, Curry SJ, et al. Treating tobacco use and dependence: 2008 Update. Clinical Practice Guideline. Rockville: U. S. Department of Health and Human Services; 2008. Public Health Service.
12. Schnoll RA, Rothman RL, Wielt DB, Lerman C, Pedri H, Wang H, et al. A randomized pilot study of cognitive-behavioral therapy versus basic health education for smoking cessation among cancer patients. Ann Beh Med. 2005;30:1-11. (Pubitemid 41208980)
13. Chelala C. Tobacco corporations step up invasion of developing countries. Lancet. 1998;351:889.
14. Dagli E. Are low income countries targets of the tobacco industry? Plenary lecture given during the Conference on Global Lung Health and 1997 Annual Meeting of the International Union Against Tuberculosis and Lung Disease, Palais des Congres, Paris, France, 1-4 October 1997. Inter J Tuberc Lung Dis. 1999;3:113-8.
15. Masironi R. Smoking control strategies in developing countries: reportof a WHO Expert Committee. World Smoking Health. 1984;9:4-6.
16. Levshin V (2001) Tactics of smoking cessation help. Smoking Situation in Russia. Proceedings of the Moscow Conference, Moscow, Russia. pp. 41-44, (in Russian)
17. Levshin V, Droggachih V (1997) Epidemiology of smoking and some determinants of smoking behavior. The Growing Epidemic. Paper presented at the 10th World Conference on Tobacco or Health, China. pp. 51-54
18. Schnoll RA, Engstrom PF, Subramanian S, Demidov L, Wielt D, Tighiouart M. Prevalence and correlates of tobacco use among Russian cancer patients: Implications for the development of smoking cessation interventions at a cancer center in Russia. Inter J Beh Med. 2006;13:16-25. (Pubitemid 44139054)
19. Markou A, Kosten TR, Koob GF. Neurobiological similarities in depression and drug dependence: a self-medication hypothesis. Neuropsychopharmacology. 1998;18:135-74. (Pubitemid 28062580)
20. Lev EL. Bandura's theory of self-efficacy: applications to oncology. Sch Inq Nurs Pract. 1997;11:21-37.
21. Prochaska JO, Di Clemente CC, Norcross JC. In search of how people change: applications to addictive behaviors. Amer Psychol. 1992;47:1102-14.
22. Koob GF, Le Moal M. Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology. 2001;24:97-129.
23. Schnoll RA, Malstrom M, James C, Rothman RL, Miller SM, Ridge JA, et al. Correlates of tobacco use among smokers and recent quitters diagnosed with cancer. Patient Educ Couns. 2002;46:137-45. (Pubitemid 34175091)
24. Schnoll RA, Rothman RL, Newman H, Lerman C, Miller SM, Movsas B, et al. Characteristics of cancer patients entering a smoking cessation program and correlates of quit motivation. Psycho oncol. 2004;13:346-58.
25. USDHHS. Smoking: Facts and Tips for Quitting. Bethesda: USDHHS; 1993.
26. Heatherton TF, Kozlowski LT, Frecker RC, Fagerström KO. The Fagerstrom Test for Nicotine Dependence: A revision of the Fagerstrom Tolerance Questionnaire. Br J Addict. 1991;86:1119-27.
27. McBride CM, Ostroff JS. Teachable moments for promoting smoking cessation: the context of cancer care and survivorship. Cancer Control. 2003;10:325-33. (Pubitemid 36919545)
28. Radloff L. The CES-D scale: A new self-report depression scale for research in the general population. Appl Psychol Measure. 1977;1:385-401.
29. Spielberger CD, Gorsuch RC, Lushene RE. Manual for the State Trait Anxiety Inventory. Palo Alto: Consulting Psychologists Press; 1970.
30. de Graeff A, de Leeuw JR, Ros WJ, Hordijk GJ, Blijham GH, Winnubst JA. Pretreatment factors predicting quality of life after treatment for head and neck cancer. Head Neck. 2000;22:398-407. (Pubitemid 30413307)
31. Tedeschi RG, Calhoun LG. The Posttraumatic Growth Inventory: measuring the positive legacy of trauma. J Trauma Stress. 1996;9:455-71. (Pubitemid 126710047)
32. Manne S, Ostroff J, Winkel G, Goldstein L, Fox K, Grana G. Posttraumatic growth after breast cancer: patient, partner, and couple perspectives. Psychosom Med. 2004;66:442-54. (Pubitemid 38668418)
33. Horn D, Waingrow S. Some dimensions of a model for smoking behavior change. Amer J Pub Health Nations Health. 1966;56:21-6.
34. Shiffman SM, Jarvik ME. Smoking withdrawal symptoms in two weeks of abstinence. Psychopharmacol Berl. 1976;50:35-9.
35. Tiffany ST, Hakenewerth DM. The production of smoking urges through an imagery manipulation: psychophysiological and verbal manifestations. Addict Beh. 1991;16:389-400.
36. Prochaska JO, Velicer WF, Rossi JS, Goldstein MG, Marcus BH, Rakowski W, et al. Stages of change and decisional balance for 12 problem behaviors. Health Psychol. 1994;13:39-46.
37. Prokhorov AV, Hudmon KS, Gritz ER. Promoting smoking cessation among cancer patients: a behavioral model. Oncology. 1997;11:1807-13. (Pubitemid 128619068)
38. Gritz ER, Fingeret MC, Vidrine DJ, Lazev AB, Mehta NV, Reece GP. Successes and failures of the teachable moment: smoking cessation in cancer patients. Cancer. 2006;106:17-27. (Pubitemid 43032545)
39. Heckman CJ, Egleston BL, Hofmann MT. Efficacy of motivational interviewing for smoking cessation: a systematic review and meta-analysis. Tob Control. 2010;19(5):410-6.
40. Shiffman S. Coping with temptations to smoke. J Consult Clin Psychol. 1984;52:261-7. (Pubitemid 15121670)
41. Gonzales D, Rennard SI, Nides M, Oncken C, Azoulay S, Billing CB. Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs. sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial. JAMA. 2006;296:47-55.
42. Henningfield JE, Fant RV, Buchhalter AR, Stitzer ML. Pharmacotherapy for nicotine dependence. CA Cancer J Clin. 2005;55:281-99. (Pubitemid 41377333)
43. Hyde J, Hankins M, Deale A, Marteau TM. Interventions to increase self-efficacy in the context of addiction behaviours: a systematic literature review. J Health Psychol. 2008;13:607-23. (Pubitemid 351758641)